-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, A/E4RtDyzTNncx8pN6IN+2/x0cVVCzSbujAJ3jWlTfPk6rjUgp6miYJS50/RVKMt S2e8sXWlsAjzDB9y+v6hyA== 0001369714-10-000002.txt : 20100504 0001369714-10-000002.hdr.sgml : 20100504 20100504140851 ACCESSION NUMBER: 0001369714-10-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100504 DATE AS OF CHANGE: 20100504 EFFECTIVENESS DATE: 20100504 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REVASCULAR THERAPEUTICS INC CENTRAL INDEX KEY: 0001369714 IRS NUMBER: 770510584 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-92148 FILM NUMBER: 10796434 BUSINESS ADDRESS: STREET 1: 766 PALOMAR AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 BUSINESS PHONE: 408-617-0770 MAIL ADDRESS: STREET 1: 766 PALOMAR AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 D/A 1 primary_doc.xml X0704 D/A LIVE 0001369714 REVASCULAR THERAPEUTICS INC 766 PALOMAR AVE SUNNYVALE CA CALIFORNIA 94085 408-617-0770 DELAWARE Norborn Medical, Inc. None Corporation true Tom Palermo c/o Revascular Therapeutics, Inc. 766 Palomar Avenue Sunnyvale CA CALIFORNIA 94085 Executive Officer Director A. Barr Dolan c/o Charter Life Sciences, L.P. 525 University Ave., Suite 1400 Palo Alto CA CALIFORNIA 94301 Director Peter Fitzgerald c/o Revascular Therapeutics, Inc. 766 Palomar Avenue Sunnyvale CA CALIFORNIA 94085 Director Michael Lynn c/o Adams Street Partners, LLC One North Wacker, Suite 2200 Chicago IL ILLINOIS 60606-2823 Director Steve Salmon c/o Latterell Venture Partners One Embarcadero Center San Francisco CA CALIFORNIA 94111 Director Carl Simpson c/o Revascular Therapeutics, Inc. 766 Palomar Avenue Sunnyvale CA CALIFORNIA 94085 Director Other Decline to Disclose 06 true 0001369714-10-000001 2008-06-27 false true false 0 6723259 6436067 287192 Total Offering Amount: $6,723,259.35 Total Amount Sold: $6,436,067.55 Total Remaining to be sold: $287,191.80 false 6 0 0 0 false REVASCULAR THERAPEUTICS INC /s/ Tom Palermo Tom Palermo President and CEO 2010-05-04 -----END PRIVACY-ENHANCED MESSAGE-----